All > Ecmo

Standard-Lung Protective Ventilation for Acute Respiratory Distress Syndrome

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Duke University Medical Center, Durham, NCAcute Respiratory Distress Syndrome+1 MoreUltra-Lung Protective Ventilation - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study how different ventilator strategies impact the treatment of patients with acute respiratory failure on ECMO. Patients will be put into two groups and assigned different ventilator protocols to compare the effects.

Eligible Conditions
  • Acute Respiratory Distress Syndrome (ARDS)
  • Acute Respiratory Failure

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
vicagrel Capsules
1
MultiStem
1
Reparixin + Standard of care

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: From study enrollment until hospital discharge or death, whichever comes first, up to 52 weeks

Week 52
Time to first ECMO weaning trial
Week 52
Duration of Hospital admission
Duration of ICU admission
Survival to discharge
Week 52
Time to meeting criteria for ECMO weaning
Week 52
Duration of ECMO
Protocol fidelity rate
Week 52
Duration of mechanical ventilation

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
vicagrel Capsules
2
MultiStem
2
Reparixin + Standard of care

Trial Design

2 Treatment Groups

Standard-Lung Protective Ventilation
1 of 2
Ultra-Lung Protective Ventilation
1 of 2

Active Control

20 Total Participants · 2 Treatment Groups

Primary Treatment: Standard-Lung Protective Ventilation · No Placebo Group · N/A

Standard-Lung Protective Ventilation
Other
ActiveComparator Group · 1 Intervention: Ultra-Lung Protective Ventilation · Intervention Types: Other
Ultra-Lung Protective Ventilation
Other
ActiveComparator Group · 1 Intervention: Standard-Lung Protective Ventilation · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: from study enrollment until hospital discharge or death, whichever comes first, up to 52 weeks

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,209 Previous Clinical Trials
3,221,276 Total Patients Enrolled
Christopher E. Cox, MDPrincipal InvestigatorDuke University

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Are individuals being accepted to participate in this investigation currently?

"According to the clinicaltrials.gov database, this research is actively looking for volunteers as of March 1st 2023; a date that coincides with its last update on the same day." - Anonymous Online Contributor

Unverified Answer

What is the current scope of participants in this clinical trial?

"Confirmed. Clinicaltrials.gov demonstrates that this medical research was first launched on March 1st, 2023 and is still recruiting participants. At present, the trial requires a total of twenty individuals from one single site to join in." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top